Search

everythinglearnresearchcommunity

for

Search:↓

Antiandrogens are somewhat effective in reducing excessive hair growth in women.

Oral dutasteride and topical pimecrolimus can safely and effectively treat Frontal Fibrosing Alopecia, leading to significant hair regrowth.

The document concludes that personalized treatment, including lifestyle changes and medication, is essential for managing PCOS in teenagers, while also addressing their psychological well-being.

The sebaceous gland has more roles than just producing sebum and contributing to acne, and new research could lead to better skin disease treatments.

The new rodent model successfully mimics non-lean human PCOS symptoms.

Moxibustion may help improve ovarian function by changing androgen levels.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

Some drugs have gained approval for new uses, while others like tricyclic antidepressants and aspirin show promise but aren't yet approved for these uses.

Hormonal treatments can help with acne, especially in women, by lowering androgen levels or blocking their effects.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Pioglitazone improved insulin sensitivity and altered cortisol metabolism in PCOS patients.

We now understand more about what causes acne and this could lead to better, more personalized treatments.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Dihydrotestosterone (DHT) increases oil production in skin cells by activating mTOR, and mTOR inhibitors can reduce this effect.

Using 5-butylpicolinate esters improves the sensitivity and reliability of detecting testosterone and dihydrotestosterone in saliva.

Estradiol and castration reduced prostate cancer development in rats when applied at early stages, but were ineffective after cancer was established.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Dutasteride reduces DHT more effectively than finasteride.

The body's change of testosterone into DHT is not necessary for testosterone's muscle and sexual effects.

Finasteride affects frog testes by increasing testosterone, decreasing 5α-DHT, and impacting genes related to reproduction and other functions.

Four-amino acid part makes enzyme sensitive to finasteride.

Exposure to finasteride in the womb caused lasting reproductive issues in male rats.

The human type II 5α-reductase gene, linked to certain male health conditions, has a specific structure and low similarity to other related genes.

The human type II 5α-reductase gene has a specific structure important for understanding certain medical conditions.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Treatment during development affects hormone balance and sexual behavior in male rats.

Finasteride may improve prostate cancer treatment outcomes.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Hormonal interactions, especially involving DHT and estrogen, play a key role in BPH development and treatment.